These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16945618)

  • 1. Open-label study of hemin for acute porphyria: clinical practice implications.
    Anderson KE; Collins S
    Am J Med; 2006 Sep; 119(9):801.e19-24. PubMed ID: 16945618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series.
    Jeans JB; Savik K; Gross CR; Weimer MK; Bossenmaier IC; Pierach CA; Bloomer JR
    Am J Med Genet; 1996 Nov; 65(4):269-73. PubMed ID: 8923933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [False surgical acute abdomen with intermittent acute porphyria].
    Mogoş D; Guran M; Marinescu S; Firescu M; Teodorescu M; Marinescu AG; Lama E
    Chirurgia (Bucur); 2004; 99(4):247-53. PubMed ID: 15560562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Porphyric crisis: experience of 30 episodes].
    Morales Ortega X; Wolff Fernández C; Leal Ibarra T; Montaña Navarro N; Armas-Merino R
    Medicina (B Aires); 1999; 59(1):23-7. PubMed ID: 10349114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute intermittent porphyria: Long-term follow up of 35 patients].
    Herrero C; Badenas C; Aguilera P; To-Figueras J
    Med Clin (Barc); 2015 Oct; 145(8):332-7. PubMed ID: 25194977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with hemin.
    Blaylock B; Epstein J; Stickler P
    J Med Econ; 2020 Jun; 23(6):537-545. PubMed ID: 31999204
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failure.
    Field JJ; Giannone L; Bessler M; Blinder MA
    Pharmacotherapy; 2006 Nov; 26(11):1662-6. PubMed ID: 17064214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with haematin in acute hepatic porphyria.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    Q J Med; 1981; 50(198):161-74. PubMed ID: 7302116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition management of acute intermittent porphyria.
    Robert TL; Varella L; Meguid MM
    Nutrition; 1994; 10(6):551-5; quiz 556-7. PubMed ID: 7703603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study.
    Sardh E; Balwani M; Rees DC; Anderson KE; Jia G; Sweetser MT; Wang B
    Orphanet J Rare Dis; 2024 Oct; 19(1):365. PubMed ID: 39363243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemin treatment in a case of porphyria variegata].
    Adam C; Hassoun A; Defresne C; Guilmot-Bruneau M; Wery-Follet B; Saussez-De Temmerman A
    Dermatologica; 1982; 165(6):640-6. PubMed ID: 7169140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute intermittent porphyria with a new protein-bound lyophilized hematin].
    Fuchs T; Ippen H
    Dtsch Med Wochenschr; 1987 Aug; 112(34):1302-5. PubMed ID: 3622268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
    Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family with acute intermittent porphyria.
    Billoo AG; Lone SW
    J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for porphyria: who, when, and how?
    Seth AK; Badminton MN; Mirza D; Russell S; Elias E
    Liver Transpl; 2007 Sep; 13(9):1219-27. PubMed ID: 17763398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of long-term treatment with hemin in the development of chronic renal failure in acute intermittent porphyria].
    García-Morillo JS; González-Estrada A; Rodriguez-Suarez S
    Med Clin (Barc); 2016 Apr; 146(8):373-4. PubMed ID: 26723937
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulatory collapse associated with hemin therapy for acute intermittent porphyria.
    Khanderia U
    Clin Pharm; 1986 Aug; 5(8):690-2. PubMed ID: 3742954
    [No Abstract]   [Full Text] [Related]  

  • 20. Early administration of heme arginate for acute porphyric attacks.
    Mustajoki P; Nordmann Y
    Arch Intern Med; 1993 Sep; 153(17):2004-8. PubMed ID: 8357285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.